Doctolib selects Diginex Limited's Plan A to turn their carbon management into strategic business value
MWN-AI** Summary
On March 19, 2026, Diginex Limited (NASDAQ: DGNX) announced a strategic partnership with Doctolib SAS, a leading healthcare technology company in Europe, to enhance carbon management through Plan A, a provider of corporate carbon accounting and decarbonization software. This collaboration aims to enable Doctolib to adopt quarterly carbon reporting and develop a comprehensive decarbonization roadmap that ties carbon reduction efforts to financial benefits, aligning with increasing investor and regulatory demands for climate transparency.
The significance of this relationship lies in Doctolib's commitment to sustainability. By leveraging Plan A's AI-driven platform, the company will build a reliable and auditable carbon management system that not only supports regulatory compliance but also creates strategic business value. Pierre Delpy, Doctolib’s Financial Control Director, emphasized that the partnership would provide clearer data for better decision-making and prioritization of carbon-reduction initiatives, helping the company uphold its B Corp certifications amidst evolving regulations.
Lubomila Jordanova, CEO of Plan A and Diginex, praised Doctolib's efforts to lead in climate strategy, highlighting the importance of engaging teams to turn insights into actionable climate initiatives. The implementation of Plan A’s platform is expected to enhance Doctolib's ability to meet stringent investor requirements and bolster its reputation as a responsible corporate entity.
With a workforce of 3,000 and a presence across over 30 cities in Europe, Doctolib supports 500,000 health professionals and 90 million patients, facilitating access to healthcare through advanced technological solutions. This collaboration signals a decisive move towards integrating sustainability in business operations, setting a precedent for other companies in the sector.
MWN-AI** Analysis
The recent announcement that Doctolib SAS has engaged in a strategic partnership with Plan A signifies an important shift in the healthcare technology sector towards sustainability and enhanced transparency. As Doctolib embarks on transitioning to quarterly carbon reporting, the emphasis on decarbonization is not merely a regulatory response but a strategic business initiative that aligns with growing investor expectations around climate responsibility.
For investors considering Diginex Limited (NASDAQ: DGNX), the integration of Plan A's carbon management framework represents a potential inflection point. By enhancing Doctolib's B Corp credentials and aligning its operational metrics with climate objectives, this collaboration is likely to bolster investor confidence, especially among those prioritizing Environmental, Social, and Governance (ESG) criteria. Companies that proactively manage their carbon footprints and report transparently on their progress are increasingly attractive to a socially conscious investor base.
The partnership also allows Doctolib to leverage advanced, AI-driven insights that not only facilitate compliance with evolving regulatory standards but also translate carbon management into tangible business value. Such foresight in strategic planning is indicative of sustainable business practices that may yield competitive advantages in securing contracts with increasingly eco-conscious clients and stakeholders.
Investors should keep a close eye on how the implementation of Plan A’s platform affects Doctolib’s operational efficiency and cost management. If successful, Doctolib could emerge as a case study in effective carbon management, potentially paving the way for the broader healthcare sector to adopt similar frameworks.
In conclusion, for current and prospective investors in Diginex, this partnership could signal increased operational resilience and long-term profitability—qualities that are vital in today’s shifting market landscape focused on sustainability. Maintaining vigilance on how this unfolds will be imperative for informed investment decisions.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
PARIS and LONDON, March 19, 2026 (GLOBE NEWSWIRE) -- Diginex Limited (NASDAQ: DGNX) today announced that Doctolib SAS, Europe's leading healthcare technology company, entered into a strategic relationship with Plan A, Europe’s leading provider of corporate carbon accounting and decarbonization software. The collaboration will enable Doctolib to transition to quarterly carbon reporting, strengthen its B Corp credentials, and build a forward-looking decarbonization roadmap that integrates CO? reduction with ?nancial impact analysis.
As investor and regulatory expectations around climate transparency intensify, Doctolib is deploying Plan A's platform for a reliable and fully auditable system. The solution will support Doctolib's reporting to investors while future-proo?ng the business for emerging regulatory requirements transforming Carbon Management into Strategic business value.
By leveraging Plan A's AI-driven insights and expert support, Doctolib will establish and implement ROI-positive climate actions.
Pierre Delpy, Financial Control Director, Doctolib: "This collaboration with Plan A gives us a stronger, more reliable, and auditable view of our carbon footprint. With clearer data, we can align teams around a single source of truth and use scenarios to quantify the real impact of speci?c actions, including their costs and bene?ts. This clarity enables us to prioritise the initiatives with the highest emissions-reduction potential, while staying aligned with our B Corp commitments and adapting to evolving regulations."
Lubomila Jordanova, CEO Plan A & Diginex, added: "We are proud to work with Doctolib, a company exemplifying exactly what climate leadership looks like in practice: shedding light on the topic of decarbonisation within the organisation to engage teams to turn insights into concrete actions. By deploying Plan A's platform, they are building the carbon intelligence infrastructure that supports stronger RFP performance, and investor-grade reporting. This is the model we want to see every forward-thinking business adopt."
About Doctolib
Since 2013, Doctolib has been supporting 500,000 health professionals and 90 million patients across Europe. We build technology that improves the daily life of health professionals and gives them more time to fully focus on their patients. Our Operating System for health professionals brings together appointment scheduling, digital secretariat, secure professional messaging, electronic health records, ?nancial solutions, and AI assistants dedicated to clinical or administrative tasks. Doctolib is also a health companion that uni?es prevention, guidance, and access to care in one place. It helps people ?nd the right professional faster, better understand their health, and bene?t from more personalized and continuous support. With 3,000 employees across more than 30 cities, Doctolib works every day alongside health professionals to build, together, the future of healthcare through trusted technology and high medical standards. (www.doctolib.com)
For more information, please visit the Company’s website: www.doctolib.com.
About Plan A
Plan A, a Diginex company, is Europe’s leading provider of corporate carbon accounting and decarbonization software. Certi?ed by TÜV Rheinland and B Corp, its AI powered platform helps thousands of businesses automate emissions management and create measurable business value.
For more information, please visit the Company’s website: www.plana.earth.
About Diginex
Diginex Limited (Nasdaq: DGNX; ISIN KYG286871044), headquartered in London, is a sustainable RegTech business that empowers businesses and governments to streamline ESG, climate, and supply chain data collection and reporting. The Company utilizes blockchain, AI, machine learning and data analysis technology to lead change and increase transparency in corporate regulatory reporting and sustainable ?nance. Diginex’s products and services solutions enable companies to collect, evaluate and share sustainability data through easy-to-use software.
For more information, please visit the Company’s website: https://www.diginex.com/.
Forward?Looking Statements
Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its ?nancial condition, results of operations, business strategy and ?nancial needs. Investors can identify these forward-looking statements by words or phrases such as “approximates,” “believes,” “hopes,” “expects,” “anticipates,” “estimates,” “projects,” “intends,” “plans,” “will,” “would,” “should,” “could,” “may” or other similar expressions. The Company undertakes no obligation to update or revise publicly any forward-looking statements to re?ect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law.
Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results disclosed in the Company's ?lings with the SEC.
Contacts: Diginex
Investor Relations
Email: ir@diginex.com
IR Contact - Europe
Anna Höffken
Phone: +49.40.609186.0
Email: diginex@kirchhoff.de
IR Contact - US
Jackson Lin
Lambert by LLYC
Phone: +1 (646) 717-4593
Email: jian.lin@llyc.global
Doctolib: presse@doctolib.com
FAQ**
How does Diginex Limited (DGNX) plan to leverage its blockchain and AI technologies to support Doctolib's carbon accounting and reporting initiatives in the healthcare sector?
What specific regulatory changes is Diginex Limited (DGNX) anticipating that will impact Doctolib's carbon management and reporting practices in the next few years?
Considering the partnership between Doctolib and Plan A, how does Diginex Limited (DGNX) envision its role in facilitating decarbonization strategies within the broader European healthcare market?
How will the collaboration between Doctolib and Plan A, supported by Diginex Limited (DGNX), influence investor confidence and transparency in corporate carbon management across Europe?
**MWN-AI FAQ is based on asking OpenAI questions about Diginex Limited (NASDAQ: DGNX).
NASDAQ: DGNX
DGNX Trading
-0.02% G/L:
$0.4743 Last:
529,324 Volume:
$0.4858 Open:
